Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
4 - 6 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Serum or plasma, frozen and protected from light
Lavender-top (EDTA) tube, red-top tube without anticoagulant, or amber plastic transport tube with amber top. (If amber tubes are unavailable, cover standard transport tube completely, top and bottom, with aluminum foil. Identify specimen with patient's name directly on the container and on the outside of the aluminum foil. Secure with tape.) For amber plastic transport tube and amber-top, order LabCorp N° 23598.
Draw blood in chilled lavender-top tubes containing EDTA or in chilled red-top tubes with no anticoagulant. Gently invert five to six times to mix if using anticoagulant tube. Keep unopened vacuum tube on ice before processing. Immediately separate plasma/serum from red cells using refrigerated centrifugation or prechilled centrifuge carrier tubes before centrifuging. Serum or plasma must be separated from cells within 45 minutes of venipuncture. Transfer serum or plasma specimen to a labeled amber transport tube and freeze on dry ice. Protect from light. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Freeze serum or plasma on dry ice in plastic amber transport tube with amber top. Not stable refrigerated. Protect from light. Stable for three months at -20°C.
Specimen not protected from light; specimen not received frozen; use of anticoagulants other than EDTA has not been studied
Vitamin K deficiency may be induced by obstructive liver disease, obstructive icterus, malabsorption due to celiac disease, pancreatitis, diarrhea, and antibiotic abuse; may be used to treat blood clotting disorders, bone metabolism disorders, and hemorrhagic disorders of newborns.
This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.
High-pressure liquid chromatography (HPLC) with electrochemical (EC) detection
• 0 to 1 year: 0.13−3.37 ng/mL
• 2 to 17 years: 0.13−1.39 ng/mL
• >17 years: 0.13−1.88 ng/mL
In humans, deficiency of vitamin K leads to decreased concentrations of circulating, active coagulation factors, which often results in bleeding. Vitamin K nutritional status has also been implicated in osteoporosis. Interest in vitamin K has increased beyond its well-established function in blood clotting with human epidemiological and intervention studies suggesting that vitamin K may reduce bone loss in osteoporotic people and decrease fracture risk.
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf